Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 12:16 AM
NCT ID:
NCT00945958
Eligibility Criteria:
Inclusion Criteria:
* Men and women aged ≥18 years
* Willing to participate and giving written informed consent
* Willing to commit to study medication-dosing, study visits and follow-up visits to complete evaluation
* Eligible to receive Latanoprost once a daily as monotherapy for treatment of glaucoma
Exclusion Criteria:
* History of allergic hypersensitivity or poor tolerance to latanoprost
* History of Substance abuse or addiction (alcohol drugs) in the past 3 years
* History of chronic use of concomitant medications in neurologic or psychiatric illness that would affect assessment of safety and effectiveness of the study medication
* Any abnormality preventing IOP measurement
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00945958
Study Brief:
Protocol Section:
NCT00945958